Shakeri A, Cicero AFG, Panahi Y, Mohajeri M, Sahebkar A, Curcumin: A naturally occurring autophagy modulator, «JOURNAL OF CELLULAR PHYSIOLOGY», 2019, 234, pp. 5643 - 5654 [articolo]
Cicero AFG, Landolfo M, Ventura F, Borghi C, Current pharmacotherapeutic options for primary dyslipidemia in adults, «EXPERT OPINION ON PHARMACOTHERAPY», 2019, 20, pp. 1277 - 1288 [articolo]
MA Calverley, Peter; Page, Clive; W Dal Negro, Roberto; Fontana, Giovanni; Cazzola, Mario; Cicero, ARRIGO FRANCESCO GIUSEPPE; Pozzi, Edoardo; A Wedzicha, Jadwiga, Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation, «INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE», 2019, 14, pp. 2733 - 2744 [articolo]Open Access
Cicero, ARRIGO FRANCESCO GIUSEPPE; Fogacci, F; Giovannini, M; Bove, M; Debellis, G; Borghi, C., Effect of quantitative and qualitative diet prescription on children behavior after diagnosis of heterozygous familial hypercholesterolemia., «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2019, 293, pp. 193 - 196 [articolo]
Cicero AFG, Cosentino ER, Kuwabara M, Degli Esposti D, Borghi C., Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients., «INTERNAL AND EMERGENCY MEDICINE», 2019, 14, pp. 949 - 956 [articolo]
Fogacci, F; Ferri, N; Toth, Pp; Ruscica, M; Corsini, A; Cicero, Afg., Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials., «DRUGS», 2019, 79, pp. 751 - 766 [articolo]
Bove M, Cicero AFG, Borghi C, Emerging drugs for the treatment of hypercholesterolemia, «EXPERT OPINION ON EMERGING DRUGS», 2019, 24, pp. 63 - 69 [articolo]
Luis E. Simental-Mendía, Mario Simental-Mendía, Adriana Sánchez-García, Maciej Banach, Maria-Corina Serban, Arrigo F. G. Cicero, Amirhossein Sahebkar, Impact of Ursodeoxycholic Acid on Circulating Lipid Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials, «LIPIDS IN HEALTH AND DISEASE», 2019, 18, Article number: 88, pp. 1 - 13 [articolo]Open Access
Cicero, A; Toth, Pp; Fogacci, F; Virdis, A; Borghi, C, Improvement in arterial stiffness after short-term treatment with PCSK9 inhibitors., «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2019, 29, pp. 527 - 529 [articolo]
Cicero, ARRIGO FRANCESCO GIUSEPPE; Fogacci, F; Giovannini, M; Grandi, E; D'Addato, S; Borghi, C; Brisighella Heart Study, Group., Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study., «JOURNAL OF HYPERTENSION», 2019, 37, pp. 728 - 731 [articolo]
Catapano AL, Barrios V, Cicero AF, Pirro M, Lifestyle interventions and nutraceuticals: Guideline-based approach to cardiovascular disease prevention, «ATHEROSCLEROSIS», 2019, 1, pp. 1 - 5 [articolo]
Andrea, Fratter; Vera, Mason; Marzia, Pellizzato; Stefano, Valier; Cicero Arrigo, F. G.; Erik, Tedesco; Elisa, Meneghetti; Federico, Benetti, Lipomatrix: A Novel Ascorbyl Palmitate-Based Lipid Matrix to Enhancing Enteric Absorption of Serenoa Repens Oil, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2019, 20, Article number: 669, pp. 1 - 26 [articolo]Open Access
Mohajeri M, Kovanen PT, Bianconi V, Pirro M, Cicero AFG, Sahebkar A, Mast cell tryptase - Marker and maker of cardiovascular diseases., «PHARMACOLOGY & THERAPEUTICS», 2019, 199, pp. 91 - 110 [articolo]
Fogacci F, Grassi D, Rizzo M, Cicero AFG, Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials., «PHYTOTHERAPY RESEARCH», 2019, 33, pp. 862 - 870 [articolo]
Cosentino, Er; Landolfo, M; Bentivenga, C; Spinardi, L; Esposti, Dd; Cicero, Af; Miceli, R; Bui, V; Berardi, E; Borghi, C, Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study., «BMC CARDIOVASCULAR DISORDERS», 2019, 19, pp. 20 - 26 [articolo]Open Access
